Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 1
1(50.0%)
2Total
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07373444Not Yet Recruiting

Westlake Aging Cohort (WeAC)

Role: collaborator

NCT06388148Not ApplicableRecruiting

Endovascular Treatment for eXtra-Large Ischemic Stroke

Role: collaborator

NCT06355258Phase 1Recruiting

A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients

Role: collaborator

All 3 trials loaded